Provided by Tiger Trade Technology Pte. Ltd.

Oppenheimer

119.61
+0.82000.69%
Post-market: 119.610.00000.00%19:30 EDT
Volume:150.66K
Turnover:18.03M
Market Cap:1.28B
PE:13.27
High:121.87
Open:117.16
Low:116.92
Close:118.79
52wk High:123.73
52wk Low:63.81
Shares:10.71M
Float Shares:6.07M
Volume Ratio:1.61
T/O Rate:2.48%
Dividend:0.76
Dividend Rate:0.64%
EPS(TTM):9.01
EPS(LYR):13.04
ROE:10.82%
ROA:2.59%
PB:1.30
PE(LYR):9.17

Loading ...

Oppenheimer Sticks to Its Buy Rating for Ovid Therapeutics (OVID)

TIPRANKS
·
Aug 14

Oppenheimer Sticks to Their Buy Rating for Selective Insurance Group (SIGI)

TIPRANKS
·
Aug 14

Oppenheimer Initiates Carriage Services at Outperform With $48 Price Target

MT Newswires Live
·
Aug 14

Oppenheimer Adjusts Elastic Price Target to $100 From $75, Maintains Outperform Rating

MT Newswires Live
·
Aug 13

Oppenheimer Adjusts PT on Crescent Capital BDC to $14 From $16, Maintains Perform Rating

MT Newswires Live
·
Aug 13

Gain Therapeutics (GANX) Gets a Buy from Oppenheimer

TIPRANKS
·
Aug 13

Oppenheimer Sticks to Their Hold Rating for Pliant Therapeutics (PLRX)

TIPRANKS
·
Aug 13

H&R Block (HRB) Receives a Hold from Oppenheimer

TIPRANKS
·
Aug 13

Legend Biotech Shares Fall After Oppenheimer Downgrade

MT Newswires Live
·
Aug 13

Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says

MT Newswires Live
·
Aug 12

H&R Indicates 'Similar' Growth for Fiscal 2027, Oppenheimer Says

MT Newswires Live
·
Aug 12

Intuitive Surgical's Competitors Face Challenges That Limit Long-Term Appeal, Oppenheimer Says

MT Newswires Live
·
Aug 12

MongoDB to Post Solid Fiscal Q2 Results on Enterprise Advanced, Atlas Upside, Oppenheimer Says

MT Newswires Live
·
Aug 12

CarGurus is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 12

Tarsus Pharmaceuticals Price Target Raised to $100.00/Share from $97.00 by Oppenheimer

Dow Jones
·
Aug 12

Snowflake Core Consumption Seen Supporting Upcoming Fiscal Q2 Results, Oppenheimer Says

MT Newswires Live
·
Aug 12

MongoDB is Maintained at Outperform by Oppenheimer

Dow Jones
·
Aug 12

Snowflake Price Target Raised to $400.00/Share from $295.00 by Oppenheimer

Dow Jones
·
Aug 12

Oppenheimer Adjusts PT on Electrovaya to $13 From $14, Maintains Outperform Rating

MT Newswires Live
·
Aug 12

Oppenheimer Adjusts PT on Cardinal Infrastructure to $70 From $80, Maintains Outperform Rating

MT Newswires Live
·
Aug 12